BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16148262)

  • 1. Evaluation of adverse effects in intracarotid propofol injection for Wada test.
    Mikuni N; Takayama M; Satow T; Yamada S; Hayashi N; Nishida N; Taki J; Enatsu R; Ikeda A; Miyamoto S; Hashimoto N
    Neurology; 2005 Dec; 65(11):1813-6. PubMed ID: 16148262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etomidate speech and memory test (eSAM): a new drug and improved intracarotid procedure.
    Jones-Gotman M; Sziklas V; Djordjevic J; Dubeau F; Gotman J; Angle M; Tampieri D; Olivier A; Andermann F
    Neurology; 2005 Dec; 65(11):1723-9. PubMed ID: 16344513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced anesthetization during the intracarotid amobarbital (Wada) test in patients taking carbonic anhydrase-inhibiting medications.
    Bookheimer S; Schrader LM; Rausch R; Sankar R; Engel J
    Epilepsia; 2005 Feb; 46(2):236-43. PubMed ID: 15679504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance.
    Fujii M; Miyachi S; Matsubara N; Kinkori T; Takebayashi S; Izumi T; Ohshima T; Tsurumi A; Hososhima O; Wakabayashi T; Yoshida J
    World Neurosurg; 2011; 75(3-4):503-8. PubMed ID: 21600504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracarotid propofol testing: a comparative study with amobarbital.
    Mikati MA; Naasan G; Tarabay H; El Yamen S; Baydoun A; Comair YG
    Epilepsy Behav; 2009 Mar; 14(3):503-7. PubMed ID: 19162226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous methylprednisolone reduces the risk of propofol-induced adverse effects during Wada testing.
    Mikuni N; Yokoyama Y; Matsumoto A; Kikuchi T; Yamada S; Hashimoto N; Miyamoto S
    Neurol Med Chir (Tokyo); 2010; 50(8):622-6. PubMed ID: 20805642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has amobarbital expired? Considering the future of the Wada.
    Grote CL; Meador K
    Neurology; 2005 Dec; 65(11):1692-3. PubMed ID: 16344509
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral Wada test: amobarbital or propofol?
    Curot J; Denuelle M; Busigny T; Barragan-Jason G; Kany M; Tall P; Marlat F; Fabre N; Valton L
    Seizure; 2014 Feb; 23(2):122-8. PubMed ID: 24252808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Wada test in the surgical treatment of temporal lobe epilepsy: an international survey.
    Baxendale S; Thompson PJ; Duncan JS
    Epilepsia; 2008 Apr; 49(4):715-20; discussion 720-5. PubMed ID: 18366477
    [No Abstract]   [Full Text] [Related]  

  • 10. Language lateralization in temporal lobe epilepsy: a comparison between fMRI and the Wada Test.
    Benke T; Köylü B; Visani P; Karner E; Brenneis C; Bartha L; Trinka E; Trieb T; Felber S; Bauer G; Chemelli A; Willmes K
    Epilepsia; 2006 Aug; 47(8):1308-19. PubMed ID: 16922875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of propofol as a replacement for amobarbital in intracarotid Wada testing of presurgical patients with epilepsy.
    McCleary K; Barrash J; Granner M; Manzel K; Greider A; Jones R
    Epilepsy Behav; 2018 Jan; 78():25-29. PubMed ID: 29169082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracarotid propofol test for speech and memory dominance in man.
    Takayama M; Miyamoto S; Ikeda A; Mikuni N; Takahashi JB; Usui K; Satow T; Yamamoto J; Matsuhashi M; Matsumoto R; Nagamine T; Shibasaki H; Hashimoto N
    Neurology; 2004 Aug; 63(3):510-5. PubMed ID: 15304583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric language mapping: sensitivity of neurostimulation and Wada testing in epilepsy surgery.
    Schevon CA; Carlson C; Zaroff CM; Weiner HJ; Doyle WK; Miles D; Lajoie J; Kuzniecky R; Pacia S; Vazquez B; Luciano D; Najjar S; Devinsky O
    Epilepsia; 2007 Mar; 48(3):539-45. PubMed ID: 17284300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accidental intra-arterial propofol injection].
    Kjaergaard M; Rovsing ML
    Ugeskr Laeger; 2010 May; 172(18):1383-4. PubMed ID: 20444411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of Wada memory asymmetry as a predictor of outcomes after temporal lobectomy.
    Kirsch HE; Walker JA; Winstanley FS; Hendrickson R; Wong ST; Barbaro NM; Laxer KD; Garcia PA
    Neurology; 2005 Sep; 65(5):676-80. PubMed ID: 16157898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated intracarotid amobarbital tests.
    Loddenkemper T; Morris HH; Lineweaver TT; Kellinghaus C
    Epilepsia; 2007 Mar; 48(3):553-8. PubMed ID: 17319921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated intracarotid amobarbital tests.
    Haber AH; Vassallo JL; Tatum WO; Benbadis SR
    Epilepsia; 2007 Sep; 48(9):1815-1816. PubMed ID: 17824949
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged cutaneous sequelae after intra-arterial injection of propofol.
    Ang BL
    Singapore Med J; 1998 Mar; 39(3):124-6. PubMed ID: 9632972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose propofol reduces the incidence of moderate to severe local pain induced by the main dose.
    Liljeroth E; Karlsson A; Lagerkranser M; Akeson J
    Acta Anaesthesiol Scand; 2007 Apr; 51(4):460-3. PubMed ID: 17378785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal memory function as reflected by the intracarotid sodium methohexital Wada test.
    Andelman F; Kipervasser S; Reider-Groswasser II; Fried I; Neufeld MY
    Epilepsy Behav; 2006 Dec; 9(4):579-86. PubMed ID: 16938491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.